Literature DB >> 26511317

Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation.

Xiaowei Sun1, Mary E Haas1, Ji Miao1, Abhiruchi Mehta1, Mark J Graham2, Rosanne M Crooke2, Jean-Paul Pais de Barros3, Jian-Guo Wang4, Masanori Aikawa4, David Masson3, Sudha B Biddinger5.   

Abstract

Diabetes is characterized by increased lipogenesis as well as increased endoplasmic reticulum (ER) stress and inflammation. The nuclear hormone receptor liver X receptor (LXR) is induced by insulin and is a key regulator of lipid metabolism. It promotes lipogenesis and cholesterol efflux, but suppresses endoplasmic reticulum stress and inflammation. The goal of these studies was to dissect the effects of insulin on LXR action. We used antisense oligonucleotides to knock down Lxrα in mice with hepatocyte-specific deletion of the insulin receptor and their controls. We found, surprisingly, that knock-out of the insulin receptor and knockdown of Lxrα produced equivalent, non-additive effects on the lipogenic genes. Thus, insulin was unable to induce the lipogenic genes in the absence of Lxrα, and LXRα was unable to induce the lipogenic genes in the absence of insulin. However, insulin was not required for LXRα to modulate the phospholipid profile, or to suppress genes in the ER stress or inflammation pathways. These data show that insulin is required specifically for the lipogenic effects of LXRα and that manipulation of the insulin signaling pathway could dissociate the beneficial effects of LXR on cholesterol efflux, inflammation, and ER stress from the negative effects on lipogenesis.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  endoplasmic reticulum stress (ER stress); fructose; inflammation; insulin; insulin resistance; lipid metabolism; lipogenesis; liver X receptor; liver insulin-receptor knockout; lysophosphatidylcholine acyltransferase 3; phospholipid; phospholipid metabolism; selective insulin resistance

Mesh:

Substances:

Year:  2015        PMID: 26511317      PMCID: PMC4714195          DOI: 10.1074/jbc.M115.668269

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors:  Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Role of LXRs in control of lipogenesis.

Authors:  J R Schultz; H Tu; A Luk; J J Repa; J C Medina; L Li; S Schwendner; S Wang; M Thoolen; D J Mangelsdorf; K D Lustig; B Shan
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

3.  A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver.

Authors:  H Yamashita; M Takenoshita; M Sakurai; R K Bruick; W J Henzel; W Shillinglaw; D Arnot; K Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

4.  Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.

Authors:  Sean B Joseph; Bryan A Laffitte; Parthive H Patel; Michael A Watson; Karen E Matsukuma; Robert Walczak; Jon L Collins; Timothy F Osborne; Peter Tontonoz
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

5.  Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.

Authors:  M D Michael; R N Kulkarni; C Postic; S F Previs; G I Shulman; M A Magnuson; C R Kahn
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

6.  The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.

Authors:  Bryan A Laffitte; Sean B Joseph; Mingyi Chen; Antonio Castrillo; Joyce Repa; Damien Wilpitz; David Mangelsdorf; Peter Tontonoz
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

7.  Liver x receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3.

Authors:  Minako Ishibashi; Alexis Varin; Rodolphe Filomenko; Tatiana Lopez; Anne Athias; Philippe Gambert; Denis Blache; Charles Thomas; Thomas Gautier; Laurent Lagrost; David Masson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-11       Impact factor: 8.311

8.  Reciprocal regulation of inflammation and lipid metabolism by liver X receptors.

Authors:  Sean B Joseph; Antonio Castrillo; Bryan A Laffitte; David J Mangelsdorf; Peter Tontonoz
Journal:  Nat Med       Date:  2003-01-13       Impact factor: 53.440

9.  Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.

Authors:  Guosheng Liang; Jian Yang; Jay D Horton; Robert E Hammer; Joseph L Goldstein; Michael S Brown
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

10.  Phospholipid transfer protein is regulated by liver X receptors in vivo.

Authors:  Guoqing Cao; Thomas P Beyer; Xiao Ping Yang; Robert J Schmidt; Youyan Zhang; William R Bensch; Raymond F Kauffman; Hong Gao; Timothy P Ryan; Yu Liang; Patrick I Eacho; Xian-Cheng Jiang
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

View more
  8 in total

1.  Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.

Authors:  Amar Bahadur Singh; Jingwen Liu
Journal:  J Biol Chem       Date:  2016-12-02       Impact factor: 5.157

Review 2.  G0S2: A small giant controller of lipolysis and adipose-liver fatty acid flux.

Authors:  Xiaodong Zhang; Bradlee L Heckmann; Latoya E Campbell; Jun Liu
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-06-21       Impact factor: 4.698

3.  KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during Fasting.

Authors:  Yoshinori Takeuchi; Naoya Yahagi; Yuichi Aita; Yuki Murayama; Yoshikazu Sawada; Xiaoying Piao; Naoki Toya; Yukari Oya; Akito Shikama; Ayako Takarada; Yukari Masuda; Makiko Nishi; Midori Kubota; Yoshihiko Izumida; Takashi Yamamoto; Motohiro Sekiya; Takashi Matsuzaka; Yoshimi Nakagawa; Osamu Urayama; Yasushi Kawakami; Yoko Iizuka; Takanari Gotoda; Keiji Itaka; Kazunori Kataoka; Ryozo Nagai; Takashi Kadowaki; Nobuhiro Yamada; Yuan Lu; Mukesh K Jain; Hitoshi Shimano
Journal:  Cell Rep       Date:  2016-08-18       Impact factor: 9.423

4.  Evaluation of hepatic CYP2D1 activity and hepatic clearance in type I and type II diabetic rat models, before and after treatment with insulin and metformin.

Authors:  Navid Neyshaburinezhad; Maryam Seidabadi; Mohammadreza Rouini; Hoda Lavasani; Alireza Foroumadi; Yalda H Ardakani
Journal:  Daru       Date:  2020-05-06       Impact factor: 3.117

5.  Liver X receptor α mediates hepatic triglyceride accumulation through upregulation of G0/G1 Switch Gene 2 expression.

Authors:  Bradlee L Heckmann; Xiaodong Zhang; Alicia M Saarinen; Gabriele Schoiswohl; Erin E Kershaw; Rudolf Zechner; Jun Liu
Journal:  JCI Insight       Date:  2017-02-23

6.  FoxO-KLF15 pathway switches the flow of macronutrients under the control of insulin.

Authors:  Yoshinori Takeuchi; Naoya Yahagi; Yuichi Aita; Zahra Mehrazad-Saber; Man Hei Ho; Yiren Huyan; Yuki Murayama; Akito Shikama; Yukari Masuda; Yoshihiko Izumida; Takafumi Miyamoto; Takashi Matsuzaka; Yasushi Kawakami; Hitoshi Shimano
Journal:  iScience       Date:  2021-11-15

7.  Endoplasmic Reticulum Stress Affects Cholesterol Homeostasis by Inhibiting LXRα Expression in Hepatocytes and Macrophages.

Authors:  Tian Wang; Yiyang Zhao; Zhongsheng You; Xiatian Li; Mingdi Xiong; Hua Li; Nianlong Yan
Journal:  Nutrients       Date:  2020-10-11       Impact factor: 5.717

8.  Different Effects of Leucine Supplementation and/or Exercise on Systemic Insulin Sensitivity in Mice.

Authors:  Xiaofan Jiang; Yuwei Zhang; Weichao Hu; Yuxiu Liang; Liang Zheng; Juan Zheng; Baozhen Wang; Xin Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-12       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.